CoChat

Prevalence of Antidepressant Use during Pregnancy in Denmark, a Nation-Wide Cohort Study

Open access
Jimenez-Solem, Espen, Andersen, Jon Trærup, Petersen, Morten, Broedbaek, Kasper, Andersen, Nadia Lyhne, Torp-Pedersen, Christian, Poulsen, Henrik Enghusen · 2013 · PLoS ONE

The DOI matches its Crossref record; 69 of the 70 references it cites were found in a registry or an index, and 1 are not checked yet.

Abstract

AIM: The aim of this study was to assess the prevalence and patterns of exposure to antidepressants before, during and after pregnancy in a cohort including all pregnant women in Denmark between 1997 and 2010. METHODS: We performed a retrospective cohort study including 912 322 pregnancies. Information was retrieved from the Danish Birth Registry and The Register of Medicinal Product Statistics to identify women redeeming an antidepressant prescription during pregnancy. Exposure periods were based on standard treatment doses and dispensed pack sizes. RESULTS: We identified 19 740 pregnancies exposed to an antidepressant at some point during pregnancy. The rate of exposure increased from 0.2% in 1997 to 3.2% in 2010. We found that the rate of exposure was halved during the first 3 months of pregnancy. In contrast, we describe a clear increase in exposure after pregnancy among pre-delivery treatment-naïve women. CONCLUSIONS: In spite of uncertainty concerning antidepressants' safety during pregnancy we find a 16-fold increase in exposure rates between 1997 and 2010. The rates describe a sharp decrease in exposure during pregnancy that is probably caused by physicians' hesitation to prescribe antidepressants and women's fear of unwanted effects on the unborn child. More studies are needed to clarify the consequences of antidepressant discontinuation during pregnancy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0063034

Cites

69 of 70 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Point prevalence of pregnant women in treatment with an antidepressant based on estimated treatment periods. SSRI, selective serotonin reuptake inhibitor; TCA, tricyclic antidepressants; AD, antidepressant.
Figure 1 Point prevalence of pregnant women in treatment with an antidepressant based on estimated treatment periods. SSRI, selective serotonin reuptake inhibitor; TCA, tricyclic antidepressants; AD, antidepressant.CC BY · PubMed Central
Figure 2 Percentage of pregnant women in treatment with an antidepressant for each day from 180 days before conception to 630 days after conception (approximately 1 year after mean time of delivery). The figure is divided into three areas of different color indicating the period of treatment start; before (dark blue), during (blue) or after pregnancy (light blue).
Figure 2 Percentage of pregnant women in treatment with an antidepressant for each day from 180 days before conception to 630 days after conception (approximately 1 year after mean time of delivery). The figure is divided into three areas of different color indicating the period of treatment start; before (dark blue), during (blue) or after pregnancy (light blue).CC BY · PubMed Central
Figure 3 Percentage of pregnant women in treatment with an SSRI for each day from 180 days before conception to 630 days after conception (approximately 1 year after mean time of delivery). Lines depict the different types of SSRIs.
Figure 3 Percentage of pregnant women in treatment with an SSRI for each day from 180 days before conception to 630 days after conception (approximately 1 year after mean time of delivery). Lines depict the different types of SSRIs.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 70 references

Cited by

See all 135

Metadata

Authors
Jimenez-Solem, E., Andersen, J. T., Petersen, M., Broedbaek, K., Andersen, N. L., Torp-Pedersen, C., & Poulsen, H. E.
Affiliations
  • Bispebjerg Hospital (DK)
  • Copenhagen University Hospital (DK)
  • University of Copenhagen (DK)
Venue
PLoS ONE
Published
2013-04-25
Volume
8
Issue
4
Pages
e63034
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2158461066
Cited by
119
References
68
Citations by year
2026: 1 · 2025: 7 · 2024: 4 · 2023: 7 · 2022: 9 · 2021: 8 · 2020: 15 · 2019: 16 · 2018: 11 · 2017: 7 · 2016: 9 · 2015: 14 · 2014: 10 · 2013: 1
FWCI
11.56
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Forsknings- og Innovationsstyrelsen
  • Danish Agency for Science and Higher Education
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
Keywords
antidepressants, pregnancy, antidepressant exposure, prevalence, maternal mental health, antidepressant discontinuation, postpartum depression, prescribing patterns, drug safety in pregnancy, Denmark
MeSH terms
Adult, Antidepressive Agents, Denmark, Female, Humans, Pregnancy, Public Health, Time Factors, Cohort Studies, Prevalence, Maternal Exposure, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prevalence of Antidepressant Use during Pregnancy in Denmark, a Nation-Wide Cohort Study. https://app.cochat.ai/papers/10.1371/journal.pone.0063034
The paper
Jimenez-Solem, E., Andersen, J. T., Petersen, M., Broedbaek, K., Andersen, N. L., Torp-Pedersen, C., & Poulsen, H. E. (2013). Prevalence of Antidepressant Use during Pregnancy in Denmark, a Nation-Wide Cohort Study. PLoS ONE. https://doi.org/10.1371/journal.pone.0063034

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.